Daniel Christ PhD

Associate Professor Daniel Christ is Head of Antibody Therapeutics and the Director of the Centre for Targeted Therapy at the Garvan Institute of Medical Research in Sydney. He holds degrees from the Swiss Federal Institute of Technology (ETH) and Cambridge University, where he worked with biotechnology pioneer Sir Gregory Winter on the development of the human antibody single domain format. His work focuses on stability engineering and structural studies of human antibodies, and on the engineering of cytokine therapeutics.